Effect of the GLP-1 receptor agonist exenatide on pro-inflammatory and metabolic biomarkers in individuals with alcohol use disorder: Post hoc results from a randomized, double-blinded, placebo-controlled clinical trial.
- DOI
- 10.1111/acer.70110
- Published
- 2025 Aug
- Container
- Alcohol, clinical & experimental research
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/acer.70110,
title = {Effect of the GLP-1 receptor agonist exenatide on pro-inflammatory and metabolic biomarkers in individuals with alcohol use disorder: Post hoc results from a randomized, double-blinded, placebo-controlled clinical trial.},
author = {Hviid MEB and Christoffersen LAN and Klausen MK and Brodersen T and Pedersen OB and Ostrowski SR and Larsen MH and Kongstad M and Jensen ME and Vilsbøll T and Fink-Jensen A},
year = {2025},
journal = {Alcohol, clinical \& experimental research},
doi = {10.1111/acer.70110},
url = {https://doi.org/10.1111/acer.70110}
}RIS
TY - JOUR TI - Effect of the GLP-1 receptor agonist exenatide on pro-inflammatory and metabolic biomarkers in individuals with alcohol use disorder: Post hoc results from a randomized, double-blinded, placebo-controlled clinical trial. AU - Hviid MEB AU - Christoffersen LAN AU - Klausen MK AU - Brodersen T AU - Pedersen OB AU - Ostrowski SR AU - Larsen MH AU - Kongstad M AU - Jensen ME AU - Vilsbøll T AU - Fink-Jensen A PY - 2025 JO - Alcohol, clinical & experimental research DO - 10.1111/acer.70110 UR - https://doi.org/10.1111/acer.70110 ER -
APA
MEB, H., LAN, C., MK, K., T, B., OB, P., SR, O., MH, L., M, K., ME, J., T, V., & A, F. (2025). Effect of the GLP-1 receptor agonist exenatide on pro-inflammatory and metabolic biomarkers in individuals with alcohol use disorder: Post hoc results from a randomized, double-blinded, placebo-controlled clinical trial.. Alcohol, clinical & experimental research. https://doi.org/10.1111/acer.70110
Source records
- pubmed · retrieved 2026-09-26T19:52:44.548Z